Advertisement

Alex Biese


First U.S. Patient Treated in Study of Novel Drug-Chemo Combo for NSCLC Subset

May 23, 2023

Work is underway in the global phase 3 HARMONi study evaluating the combination of ivonescimab and chemotherapy in the treatment of patients with EGFR-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer.

Advertisement
Advertisement